Intercure

Price Chart

Risk-Adjusted Performance

Also Listed On

Intercure (INCR) Price Performance

Intercure (INCR) trades on TA in ILS. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at ILS271.50, up 19.08% from the previous close.

Over the past year, INCR has traded between a low of ILS228.00 and a high of ILS595.00. The stock has lost 48.8% over this period. It is currently 54.4% below its 52-week high.

Intercure has a market capitalization of $125.93M.

About Intercure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis therapeutics. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.